Research identifies small molecule drug candidate

The Univ of Montreal's Institute for Research in Immunology and Cancer, the Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) and Bristol Myers Squibb, have identified a small molecule drug candidate against a novel target. The discovery triggers a milestone payment to U of M and validates IRICoR's business model of working closely with major pharmaceutical c